Newly described or emerging human species of nontuberculous mycobacteria

Infectious Disease Clinics of North America

Volumn 16, Issue 1, 2002, Pages 187-220

  Brown Elliott, Barbara A ^a,b   Griffith, David E ^b   Wallace Jr , Richard J ^b  

^a Mycobacteria/Nocardia Laboratory   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMPHOTERICIN B; AZLOCILLIN; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; CYCLOSERINE; DOXYCYCLINE; ETHAMBUTOL; GATIFLOXACIN; GENTAMICIN; ISONIAZID; KANAMYCIN; MACROLIDE; MOXIFLOXACIN; NALIDIXIC ACID; OFLOXACIN; POLYMYXIN B; PROTIONAMIDE; QUINOLONE DERIVATIVE; RIFABUTIN; RIFAMPICIN; SPARFLOXACIN; SULFONAMIDE; TRIMETHOPRIM; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; GENOTYPE; HUMAN; MYCOBACTERIUM; MYCOBACTERIUM ALVEI; MYCOBACTERIUM BRUMAE; MYCOBACTERIUM CELATUM; MYCOBACTERIUM CONFLUENTIS; MYCOBACTERIUM CONSPICUUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GENAVENSE; MYCOBACTERIUM GOODII; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM HASSIACUM; MYCOBACTERIUM IMMUNOGENUM; MYCOBACTERIUM INTERJECTUM; MYCOBACTERIUM INTERMEDIUM; MYCOBACTERIUM LENTIFLAVUM; MYCOBACTERIUM MAGERITENSE; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MUCOGENICUM; MYCOBACTERIUM NOVOCASTRENSE; MYCOBACTERIUM SEPTICUM; MYCOBACTERIUM TRIPLEX; MYCOBACTERIUM ULCERANS; MYCOBACTERIUM WOLINSKYI; MYCOBACTERIUM XENOPEI; NONHUMAN; PHENOTYPE; REVIEW; SPECIES DIFFERENTIATION;

EID: 0036129869     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(03)00052-7     Document Type: Review

References (155)

1. Pulmonary disease caused by Mycobacterium malmoense
2. Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis
3. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children
4. Infection due to Mycobacterium haemophilum identified by whole cell lipid analysis and nucleic acid sequencing
5. Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin
6. Mycobacterium alvei sp. nov.
7. Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis
8. Bronchoscopy-associated Mycobacterium xenopi pseudoinfections
9. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum
10. Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus
11. Nontuberculous pulmonary infections in Scotland: A cluster in Lothian?
12. The occurrence of atypical mycobacteria in the environment of man and animal
13. Mycobacterium celatum infection in a patient with AIDS
14. Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: Diagnosis by culture-free microbiological methods
15. Mycobacterium genavense: An emerging pathogen
16. Mycobacterium genavense sp. nov.
17. Disseminated "Mycobacterium genavense" infection in patients with AIDS
18. Characterization of a distinct group of slowly growing mycobacteria by biochemical tests and lipid analyses
19. Description of Mycobacterium wolinskyi and Mycobacterium goodii, two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: A cooperative study from the International Working Group on Mycobacterial Taxonomy
20. Use of E test for clarithromycin susceptibility testing of Mycobacterium haemophilum
21. Mycobacterium malmoense infections in the United States, January 1993 through June 1995
22. A new group (Type 3) of Mycobacterium celatum isolates from AIDS patients in the London area
23. Isolation of Mycobacterium xenopei from water taps
24. Cross-reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum
25. Mycobacterium celatum sp. nov.
26. Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient
27. Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense
28. Disseminated infection due to Mycobacterium malmoense in a patient infected with human immunodeficiency virus
29. Disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy
30. Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients
31. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum
32. Mycobacterium interjectum as a causative agent of cervical lymphadenitis
33. Spinal infections (SI) due to Mycobacterium xenopi after discectomies (DC)
34. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS
35. Emergence of a unique group of necrotizing mycobacterial diseases
36. Mycobacterium mageritense sp. nov.
37. Chronic destructive lung disease associated with a novel mycobacterium
38. Mycobacterium kubicae sp. nov., a slowly growing, scotochromogenic Mycobacterium
39. Characterization of an SAV organism and proposal of Mycobacterium triplex sp. nov.
40. Mycobacterium genavense and cutaneous disease in AIDS
41. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine
42. Cutaneous Mycobacterium malmoense infection in an immunocompromised patient
43. Disseminated Mycobacterium genavense infection in two patients with AIDS
44. Bacteriologically confirmed nontuberculous mycobacterial lymphadenitis in southeast England: A recent increase in the number of cases
45. Origin and significance of Mycobacterium xenopi in clinical specimens
46. A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov.
47. Mycobacterium lentiflavum: An etiologic agent of cervical lymphadenitis
48. Novel mycobacterium related to Mycobacterium triplex as a cause of cervical lymphadenitis
49. Susceptibilities of Mycobacterium malmoense determined at the growth optimum pH (pH 6.0)
50. Infection with Mycobacterium malmoense in Sweden: Report of 221 cases
51. Mycobacterium triplex infection in a liver transplant patient
52. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria
53. Mycobacterium malmoense: An easily missed pathogen
54. Central line sepsis in a child due to a previously unidentified mycobacterium
55. Mycobacteriosis due to Mycobacterium genavense in six pet birds
56. Molecular method for typing Mycobacterium ulcerans
57. The emergence of Mycobacterium ulcerans infection near Melbourne
58. Mycobacterium hiberniae sp. nov.
59. Septic arthritis in the knee due to Mycobacterium xenopi in a patient undergoing hemodialysis
60. Mycobacterium haemophilum: An emerging pathogen
61. Mycobacterium confluentis sp. nov.
62. Mycobacterium branderi sp. nov., a new potential human pathogen
63. Multiplex PCR assay for immediate identification of the infecting species in patients with mycobacterial disease
64. Mycobacterium haemophilum infection in immunocompromised patients: Case report and review of the literature
65. Buruli ulcer in New York City
66. Phenotypic and molecular characterization of three clinical isolates of Mycobacterium interjectum
67. Mycobacterium brumae sp. nov., a rapidly growing, nonphotochromogenic mycobacterium
68. A new mycobacterial infection in man
69. Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: Utility of epidemiologic and laboratory investigation
70. Emergence of Buruli ulcer in the Daloa region of Cote d'Ivoire
71. Laboratory and clinical evaluation of Mycobacterium xenopi isolates
72. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections
73. The isolation of M. Kansasii and M. xenopi from water systems
74. Mycobacterium intermedium sp. nov.
75. Mycobacterial contamination of metal working fluids: Involvement of a possible new taxon of rapidly growing mycobacteria
76. Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency virus-infected patient
77. Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system
78. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients
79. A study of Mycobacterium fortuitum (ranae)
80. Pseudoepidemic of Mycobacterium abscessus associated with bronchoscopy
81. Mycobacterium heidelbergense species nov. infection mimicking a lung tumor
82. Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus
83. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: Case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine
84. Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization
85. Biochemical properties and fatty acid composition of Mycobacterium haemophilum: Study of 16 isolates from Australian patients
86. Pulmonary disease caused by Mycobacterium malmoense. Comments on the possible origin of infection and methods for laboratory diagnosis
87. Isolation of Mycobacterium malmoense from the environment in Zaire
88. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin
89. Primary psoas muscle abscess due to Mycobacterium xenopi
90. Microaerophilic conditions promote growth of Mycobacterium genavense
91. Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures
92. Mycobacterium bohemicum sp. nov., a new slow-growing scotochromogenic mycobacterium
93. Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography
94. Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans
95. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome
96. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection
97. Mycobacterium heckeshornense sp. nov., a new pathogenic slowly growing Mycobacterium sp. causing cavitary lung disease in an immunocompetent patient
98. New characteristics of Mycobacterium haemophilum
99. Mycobacterium haemophilum: Microbiology and expanding clinical and geographic spectra of disease in humans
100. Bronchopulmonary infection with Mycobacterium malmoense presenting as a bronchoesophageal fistula
101. Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia
102. Mycobacterium malmoense sp. nov.
103. Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic mycobacterium
104. A strain of mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid fast bacilli occurring in man
105. Mycobacterium novocastrense sp. nov., a rapidly growing photochromogenic mycobacterium
106. Identification of clinically significant Mycobacterium fortuitum complex isolates
107. The role of Mycobacterium xenopi in human disease
108. False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay
109. Mycobacterium haemophilum sp. nov., a new pathogen of humans
110. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov.
111. Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis
112. Mycobacterium conspicuum sp. nov., a new species isolated from patients with disseminated infections
113. Isolation and characterization of a unique group of slowly growing mycobacteria: Description of Mycobacterium lentiflavum sp. nov.
114. The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria
115. PCR amplification and restriction endonuclease analysis of a 65-Kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria
116. A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans
117. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients
118. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae
119. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis
120. Two cases of Mycobacterium haemophilum infection in Canada
121. Disseminated infection with Mycobacterium genavense: A challenge to physicians and mycobacteriologists
122. Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: Mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis
123. Characterization of Mycobacterium bohemicum isolated from human, veterinary, and environmental sources
124. Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov.
125. Cervical lymphadenitis due to Mycobacterium bohemicum
126. Cervical lymphadenitis due to an unusual mycobacterium
127. Mycobacterium tusciae sp. nov.
128. Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae
129. Isolation of the newly described species Mycobacterium celatum from AIDS patients
130. Mycobacterium xenopi isolation from clinical specimens in the Florence area: Review of 46 cases
131. Evaluation of a simple method for growing Mycobacteriurn haemophilum
132. Infection with a fastidious mycobacterium resembling Mycobacterium simiae in seven patients with AIDS
133. Nontuberculous mycobacteria
134. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum
135. Request for clarification of the difference between M. mageritense sp. nov. and M. smegmatis
136. Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid
137. Human disease due to Mycobacterium smegmatis
138. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism
139. First report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacteria Taxonomy
140. Agents of newly recognized or infrequently encountered mycobacterial diseases
141. A new mycobacterial species related to Mycobacterium abscessus associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: Mycobacterium immunogenum sp. nov. - An international cooperative study on mycobacterial taxonomy
142. Use of PCR restriction fragment analysis (PRA) for separation of Mycobacterium simiae-lentiflavum triplex complex
143. Use of PCR restriction fragment analysis (PRA) for separation of the Mycobacterium simiae-lentiflavum-triplex complex
144. Mycobacterium branderi from both a hand infection and a case of pulmonary disease
145. Nontuberculous mycobacteria and associated diseases
146. Mycobacterium xenopi and Mycobacterium kansasii in a hospital water supply
147. Isolation of environmental mycobacteria from clinical specimens in Southeast England: 1973-1993
148. 16S rRNA sequence analysis of an isolate of Mycobacterium haemophilum from a heart transplant patient
149. Extrapulmonary and disseminated infections due to Mycobacterium malmoense: Case report and review
150. Nontuberculous mycobacterial tenosynovitis: Report of two cases
151. Pneumonia and bacteremia due to Mycobacterium celatum masquerading as Mycobacterium xenopi in patients with AIDS: An under-diagnosed problem?